Bill > S3128

Introduced Session

This bill requires health benefits plans to cover abuse-deterrent analgesic opioid drug products. Under the bill, a carrier will be required to provide coverage and benefits, on its prescription drug formulary list, for at least one abuse-deterrent opioid analgesic drug product per opioid analgesic active ingredient. The bill also provides that cost-sharing for a brand name or generic abuse-deterrent opioid analgesic drug product is not to exceed the lowest cost-sharing amount applied to a brand name or generic non-abuse deterrent opioid drug, respectively. Finally, the bill provides that any prior-authorization requirements or other utilization review requirements for an opioid analgesic, and any service denials made thereunder, are prohibited from requiring a covered person or enrollee to use an opioid analgesic drug product without abuse-deterrent properties before a covered person or enrollee can access an abuse-deterrent opioid analgesic drug product.

Committee Categories

Brian Stack (D)*, 

Introduced in the Senate, Referred to Senate Commerce Committee (on 04/15/2024)

Official Document